Healthcare -
Biotechnology - NASDAQ - US
$ 18.05
2.67 %
$ 1.24 B
Market Cap
-3.77
P/E
ARVN - LONG-TERM DEBT
Long-term Debt ARVN - Arvinas, Inc.
1.3 M
LAST VALUE
-42.26%
2 YEAR CAGR
-8.25%
5 YEAR CAGR
0.00%
10 YEAR CAGR